Success Metrics

Clinical Success Rate
94.1%

Based on 16 completed trials

Completion Rate
94%(16/17)
Active Trials
1(5%)
Results Posted
6%(1 trials)
Terminated
1(5%)

Phase Distribution

Ph phase_1
3
14%
Ph phase_2
3
14%
Ph not_applicable
2
10%
Ph phase_4
6
29%
Ph phase_3
6
29%

Phase Distribution

3

Early Stage

3

Mid Stage

12

Late Stage

Phase Distribution20 total trials
Phase 1Safety & dosage
3(15.0%)
Phase 2Efficacy & side effects
3(15.0%)
Phase 3Large-scale testing
6(30.0%)
Phase 4Post-market surveillance
6(30.0%)
N/ANon-phased studies
2(10.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

94.1%

16 of 17 finished

Non-Completion Rate

5.9%

1 ended early

Currently Active

1

trials recruiting

Total Trials

21

all time

Status Distribution
Active(1)
Completed(16)
Terminated(1)
Other(3)

Detailed Status

Completed16
unknown3
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
1
Success Rate
94.1%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (15.0%)
Phase 23 (15.0%)
Phase 36 (30.0%)
Phase 46 (30.0%)
N/A2 (10.0%)

Trials by Status

completed1676%
unknown314%
recruiting15%
terminated15%

Recent Activity

1 active trials
Showing 5 of 21
terminatedphase_1

Clinical Assessment of Protopic® Ointment in Deep Partial-Thickness Burns

NCT05856994
completedphase_2

A Comparative Clinical Trial Evaluating the Effect and Safety of Tacrolimus Versus Hydrocortisone

NCT05607901
recruitingphase_2

Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma

NCT04056962
completednot_applicable

Efficacy and Safety of 308-nm Excimer Lamp Combined With Tacrolimus vs Tacrolimus as Monotherapy in Treating Vitiligo on Children

NCT06035614
completednot_applicable

Uses of Tacrolimus in Behcet Disease

NCT05032248
View all 21 trials

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT05856994Phase 1

Clinical Assessment of Protopic® Ointment in Deep Partial-Thickness Burns

Terminated
NCT05607901Phase 2

A Comparative Clinical Trial Evaluating the Effect and Safety of Tacrolimus Versus Hydrocortisone

Completed
NCT04056962Phase 2

Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma

Recruiting
NCT06035614Not Applicable

Efficacy and Safety of 308-nm Excimer Lamp Combined With Tacrolimus vs Tacrolimus as Monotherapy in Treating Vitiligo on Children

Completed
NCT05032248Not Applicable

Uses of Tacrolimus in Behcet Disease

Completed
NCT04390685Phase 1

Prevention of Breast Cancer-related Lymphedma With Tacrolimus

Unknown
NCT04267991

Corneal Densitometry Changes With Adenoviral SEI

Completed
NCT00654355Phase 4

Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit

Completed
NCT03234673Phase 1

The Effect of Fractional Co2 Laser Either With Tacrolimus, Calcipotriol or NB-UVB in Stable Generalized Vitiligo

Unknown
NCT00480610Phase 3

Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus Ointment

Completed
NCT00667056Phase 4

Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact Dermatitis

Completed
NCT00480896Phase 3

Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment

Completed
NCT00667160Phase 4

Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic Dermatitis

Completed
NCT00666302Phase 4

A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitis

Completed
NCT00666159Phase 4

Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic Dermatitis

Completed
NCT00691262Phase 3

Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic Dermatitis

Completed
NCT00691145Phase 3

Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic Dermatitis

Completed
NCT00523952Phase 3

Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult Patients

Completed
NCT01333410Phase 4

Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult Vitiligo

Unknown
NCT00807690Phase 3

Vitiligo Treated With TL01 Combined With Tacrolimus Ointment Versus Placebo

Completed

Drug Details

Intervention Type
DRUG
Total Trials
21